Covered recipient · General Payments record
HUGO ESCOBAR
Allopathic & Osteopathic Physicians Pediatrics Pediatric Pulmonology
General Payments · PY2018–2024
$1,401.29
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.78 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $119.11 | 2 |
| Mylan Specialty L.P. | $80.91 | 1 |
| ABBVIE INC. | $39.90 | 2 |
| BAXTER HEALTHCARE | $37.02 | 2 |
| Amgen Inc. | $23.03 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.81 | 1 |
| Electromed, Inc. | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.81 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103698052 | CMS |
| ABBVIE INC. | $23.09 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103698054 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.81 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146961264 | CMS |
| Amgen Inc. | $23.03 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570967 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.65 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104619984 | CMS |
| AstraZeneca Pharmaceuticals LP | $99.46 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104550442 | CMS |
| Baxter Healthcare | $16.17 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120636306 | CMS |
| Baxter Healthcare | $20.85 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120636311 | CMS |
| Electromed, Inc. | $14.00 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137888534 | CMS |
| Mylan Specialty L.P. | $80.91 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147309442 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.